Yumi Mochizuki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yumi Mochizuki has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Hiroyuki Harada
7 shared publicationsHideaki Hirai
Department of Oral and Maxillofacial surgery, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan
5 shared publicationsKen Omura
Departments of Oral and Maxillofacial Surgery and Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8549, Japan
5 shared publicationsTakuma Kugimoto
Department of Oral and Maxillofacial surgery, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan
5 shared publicationsHirofumi Tomioka
Department of Oral and Maxillofacial surgery, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan
4 shared publications- Hiroyuki Harada
Department of Oral and Maxillofacial Surgical Oncology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan
3 shared publications
Latest Publications
- 1 April 2023
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
- Vol. 17 (4) , KC01-KC04
Effects of Royal Jelly Supplementation on Dry Mouth Sensation in Patients with Normal Saliva Function: A Randomised Clinical Study
Introduction: In several cases, dry mouth sensation with normal salivary function is not diagnosed as an abnormality and this condition has no standardised treatments. Moreover, it is significantly associated with psychological disorders such as depression, trait anxiety and perceived stress. Based on recent studies, daily oral royal jelly supplementation (1000 mg) for eight weeks has beneficial effects on menopausal symptoms such as anxiety. However, there are no studies on the effects of royal jelly supplementation on dry mouth sensation in patients with normal salivary function. Further, only few clinical trials have long-term follow-up greater than eight weeks. Aim: To evaluate the effects of royal jelly tablets on dry mouth sensation in patients with normal salivary function. Materials and Methods: This randomised, double-blind, crossover clinical trial included 15 adults with an unstimulated salivary flow of >0.1 mL/min who had a chief complaint of dry mouth sensation and those without any salivary gland disease. This study was performed at Tokyo Medical and Dental University Hospital, Tokyo, Japan, between November 2019 and April 2020. The royal jelly tablet contained 400 mg of enzyme-treated royal jelly powder and each participant received either two tablets of enzyme-treated royal jelly (800 mg) or placebo daily for 12 weeks. The Visual Analogue Scale (VAS) was used to evaluate objective dry mouth sensation and the Japanese version of the Hospital Anxiety and Depression Scale (HADS) and General Health Questionnaire 12 (GHQ-12) were applied to assess psychological status and social dysfunction. The differences in VAS, HADS and GHQ-12 scores over time between the enzyme-treated royal jelly and placebo groups were analysed using repeated-measure analysis of variance and the post-hoc paired t-test. Results: The 4- and 12-week VAS scores between the enzymetreated royal jelly and placebo groups significantly differed (p-value=0.041 and 0.043, respectively). The 12-week HADS and GHQ-12 scores between the enzyme-treated royal jelly tablet and placebo groups differed significantly (p-value=0.040 and 0.046, respectively). Moreover, the HADS scores of the enzyme-treated royal jelly tablet group significantly decreased. Conclusion: Daily supplementation with enzyme-treated royal jelly (800 mg) for 12 weeks was effective against dry mouth sensation in patients with normal saliva function.
- 1 April 2023
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
- Vol. 17 (4) , KC01-KC04
Effects of Royal Jelly Supplementation on Dry Mouth Sensation in Patients with Normal Saliva Function: A Randomised Clinical Study
Introduction: In several cases, dry mouth sensation with normal salivary function is not diagnosed as an abnormality and this condition has no standardised treatments. Moreover, it is significantly associated with psychological disorders such as depression, trait anxiety and perceived stress. Based on recent studies, daily oral royal jelly supplementation (1000 mg) for eight weeks has beneficial effects on menopausal symptoms such as anxiety. However, there are no studies on the effects of royal jelly supplementation on dry mouth sensation in patients with normal salivary function. Further, only few clinical trials have long-term follow-up greater than eight weeks. Aim: To evaluate the effects of royal jelly tablets on dry mouth sensation in patients with normal salivary function. Materials and Methods: This randomised, double-blind, crossover clinical trial included 15 adults with an unstimulated salivary flow of >0.1 mL/min who had a chief complaint of dry mouth sensation and those without any salivary gland disease. This study was performed at Tokyo Medical and Dental University Hospital, Tokyo, Japan, between November 2019 and April 2020. The royal jelly tablet contained 400 mg of enzyme-treated royal jelly powder and each participant received either two tablets of enzyme-treated royal jelly (800 mg) or placebo daily for 12 weeks. The Visual Analogue Scale (VAS) was used to evaluate objective dry mouth sensation and the Japanese version of the Hospital Anxiety and Depression Scale (HADS) and General Health Questionnaire 12 (GHQ-12) were applied to assess psychological status and social dysfunction. The differences in VAS, HADS and GHQ-12 scores over time between the enzyme-treated royal jelly and placebo groups were analysed using repeated-measure analysis of variance and the post-hoc paired t-test. Results: The 4- and 12-week VAS scores between the enzymetreated royal jelly and placebo groups significantly differed (p-value=0.041 and 0.043, respectively). The 12-week HADS and GHQ-12 scores between the enzyme-treated royal jelly tablet and placebo groups differed significantly (p-value=0.040 and 0.046, respectively). Moreover, the HADS scores of the enzyme-treated royal jelly tablet group significantly decreased. Conclusion: Daily supplementation with enzyme-treated royal jelly (800 mg) for 12 weeks was effective against dry mouth sensation in patients with normal saliva function.
- Open Access
- 26 January 2022
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 16 (1) , 1-7
Left supraclavicular (Virchow’s) node metastasis detected before primary infradiaphragmatic tumor: a case series
Background: Metastasis of infradiaphragmatic tumors to the left supraclavicular lymph node is reported to be rare. When metastasis is detected in the left supraclavicular node in patients with head and neck carcinoma, locating the primary cancer remains a difficult and time-consuming challenge despite the dramatic development of screening technologies and treatment methods. Case presentation: We report three cases of malignant infradiaphragmatic tumor diagnosed following an initial finding of left supraclavicular node metastasis after surgery for tongue squamous cell carcinoma (follow-up period, range 18–62 months). In these cases, adenocarcinoma was diagnosed based on left supraclavicular node biopsies, and a second primary tumor was found, in a 78-year-old Japanese woman with a diagnosis of cholangiocarcinoma, a 64-year-old Japanese man with a diagnosis of bladder carcinoma, and a 61-year-old Japanese man with a diagnosis of prostate carcinoma. In the cholangiocarcinoma case, carbohydrate antigen 19-9 and alpha-fetoprotein levels helped to diagnose cholangiocarcinoma. Palliative care only was given, with survival for 11 months after diagnosis of lymph node metastasis. In the bladder carcinoma case, pathological analysis of fine-needle aspiration biopsy specimen of the metastatic cervical lymph node showed atypical cells with slight squamous differentiation. Hematoxylin–eosin staining of the bladder lesion did not identify a clear glandular or squamous component, and we could not make a definitive diagnosis of whether the lesion was poorly differentiated squamous cell carcinoma, adenocarcinoma, or high-grade urothelial carcinoma. GATA3 staining aided in the diagnosis of urothelial bladder cancer with left supraclavicular node metastasis. He survived for 2 months after diagnosis of left supraclavicular lymph node metastasis. In the prostate carcinoma case, 18F‐fluorodeoxyglucose uptake was weak. Prostate-specific antigen levels and magnetic resonance imaging findings aided the diagnostic process. This patient underwent bilateral orchiectomy and adjuvant hormonal therapy and survived for 47 months after diagnosis of left supraclavicular node metastasis. Conclusions: Pathological diagnosis on the basis of immunohistochemistry and specific diagnosis methods such as radiological and serological assessments are important for providing rapid diagnosis and appropriate treatment.
- 26 January 2022
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 16 (1) , 1-7
Open AccessLeft supraclavicular (Virchow’s) node metastasis detected before primary infradiaphragmatic tumor: a case series
Background: Metastasis of infradiaphragmatic tumors to the left supraclavicular lymph node is reported to be rare. When metastasis is detected in the left supraclavicular node in patients with head and neck carcinoma, locating the primary cancer remains a difficult and time-consuming challenge despite the dramatic development of screening technologies and treatment methods. Case presentation: We report three cases of malignant infradiaphragmatic tumor diagnosed following an initial finding of left supraclavicular node metastasis after surgery for tongue squamous cell carcinoma (follow-up period, range 18–62 months). In these cases, adenocarcinoma was diagnosed based on left supraclavicular node biopsies, and a second primary tumor was found, in a 78-year-old Japanese woman with a diagnosis of cholangiocarcinoma, a 64-year-old Japanese man with a diagnosis of bladder carcinoma, and a 61-year-old Japanese man with a diagnosis of prostate carcinoma. In the cholangiocarcinoma case, carbohydrate antigen 19-9 and alpha-fetoprotein levels helped to diagnose cholangiocarcinoma. Palliative care only was given, with survival for 11 months after diagnosis of lymph node metastasis. In the bladder carcinoma case, pathological analysis of fine-needle aspiration biopsy specimen of the metastatic cervical lymph node showed atypical cells with slight squamous differentiation. Hematoxylin–eosin staining of the bladder lesion did not identify a clear glandular or squamous component, and we could not make a definitive diagnosis of whether the lesion was poorly differentiated squamous cell carcinoma, adenocarcinoma, or high-grade urothelial carcinoma. GATA3 staining aided in the diagnosis of urothelial bladder cancer with left supraclavicular node metastasis. He survived for 2 months after diagnosis of left supraclavicular lymph node metastasis. In the prostate carcinoma case, 18F‐fluorodeoxyglucose uptake was weak. Prostate-specific antigen levels and magnetic resonance imaging findings aided the diagnostic process. This patient underwent bilateral orchiectomy and adjuvant hormonal therapy and survived for 47 months after diagnosis of left supraclavicular node metastasis. Conclusions: Pathological diagnosis on the basis of immunohistochemistry and specific diagnosis methods such as radiological and serological assessments are important for providing rapid diagnosis and appropriate treatment.
- Open Access
- 30 December 2021
- Published by Springer Nature in Research Square
The Effects of The Royal Jelly On Dry Mouth Sensation With Normal Saliva Function: A Double-Blind, Placebo-Controlled, Cross-Over Trial Clinical Study
Background: Because there are no standardized treatment methods for dry mouth sensation with normal salivary function, cases of dry mouth sensation continually suffer. The aim of this clinical study was to evaluate the effects of a royal jelly tablets on dry mouth sensation, in patients with normal salivary function. Methods: This double-blind randomized clinical trial was carried out in the Department of Oral and Maxillofacial Surgery, Tokyo Medical and Dental University Hospital between November, 2019 and April, 2020. This clinical trial was randomized, double-blind, and of a crossover design, with a four-week washout period. Each participant received either 800 mg of royal jelly tablets or placebo, daily for 12 weeks. Results: Differences in VAS scores between royal jelly tablets and placebo were evaluated at 4 and 12 weeks, and were significant. Differences in HADS and GHQ12 scores between those exposed to royal jelly tablets and placebo, at the evaluation period of 12 weeks, were statistically significant. A statistically significant decrease in HADS scores in the royal jelly tablet group, was observed over time. Conclusions: These findings show that daily consumption of royal jelly (800 mg) for 12 weeks was effective in alleviating dry mouth sensation with normal saliva function.Clinical trial registration numbers and the full date of first registration: ClinicalTrials.gov (jRCTs031190067); 02/08/2019
- 30 December 2021
- Published by Springer Nature in Research Square
Open AccessThe Effects of The Royal Jelly On Dry Mouth Sensation With Normal Saliva Function: A Double-Blind, Placebo-Controlled, Cross-Over Trial Clinical Study
Background: Because there are no standardized treatment methods for dry mouth sensation with normal salivary function, cases of dry mouth sensation continually suffer. The aim of this clinical study was to evaluate the effects of a royal jelly tablets on dry mouth sensation, in patients with normal salivary function. Methods: This double-blind randomized clinical trial was carried out in the Department of Oral and Maxillofacial Surgery, Tokyo Medical and Dental University Hospital between November, 2019 and April, 2020. This clinical trial was randomized, double-blind, and of a crossover design, with a four-week washout period. Each participant received either 800 mg of royal jelly tablets or placebo, daily for 12 weeks. Results: Differences in VAS scores between royal jelly tablets and placebo were evaluated at 4 and 12 weeks, and were significant. Differences in HADS and GHQ12 scores between those exposed to royal jelly tablets and placebo, at the evaluation period of 12 weeks, were statistically significant. A statistically significant decrease in HADS scores in the royal jelly tablet group, was observed over time. Conclusions: These findings show that daily consumption of royal jelly (800 mg) for 12 weeks was effective in alleviating dry mouth sensation with normal saliva function.Clinical trial registration numbers and the full date of first registration: ClinicalTrials.gov (jRCTs031190067); 02/08/2019
- 1 September 2021
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 74 (9) , 1984-1990
Postoperative morphological changes over time of vascularized scapular bone used for mandibular reconstruction: A retrospective cohort study
- 1 September 2021
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 74 (9) , 1984-1990
Postoperative morphological changes over time of vascularized scapular bone used for mandibular reconstruction: A retrospective cohort study
- Open Access
- 10 August 2021
- Published by Springer Nature in Research Square
Left Supraclavicular (Virchow’s) Node Metastasis Detected Before Diagnosis of the Primary Infradiaphragmatic Tumor
Background and Purpose: Malignant infradiaphragmatic tumors that metastasize to the left supraclavicular (Virchow’s) node are relatively rare. Since Virchow's time, the survival rates of cancer patients have improved because of dramatic research advances in the epidemiology of cancer and the development of screening technologies and treatment methods. However, when metastasis is detected in the left supraclavicular node in patients with head and neck carcinoma, locating the primary cancer remains a difficult and time-consuming challenge. We report three cases of malignant infradiaphragmatic tumors diagnosed following the initial finding of left supraclavicular node (LSN) metastasis after surgery for tongue squamous cell carcinoma (follow-up period, range 18–62 months).Methods: In these cases, adenocarcinoma was diagnosed based on LSN biopsies, and a second primary tumor was found, including cholangiocarcinoma, bladder carcinoma, and prostate carcinoma.Results: CA19-9 and alpha-fetoprotein levels helped to diagnose cholangiocarcinoma. In the bladder carcinoma case, immunopathological examination of the metastatic LSN and bladder lesion showed GATA 3(+), and the tongue squamous cell carcinoma showed GATA 3(-). GATA 3 staining aided in the diagnosis of urothelial bladder cancer with LSN metastasis. In the prostate carcinoma case, PSA levels and weak FDG-PET/CT uptake aided the diagnosis process. This patient underwent bilateral orchiectomy and adjuvant hormonal therapy and survived for 47 months after the diagnosis of LSN metastasis. The other patients died within 1 year.Discussion and Conclusions: These cases suggest that the prognosis of malignant infradiaphragmatic tumors after LSN metastasis depends on the tumor characteristics and that rapid diagnosis is important for providing appropriate treatment.
- 10 August 2021
- Published by Springer Nature in Research Square
Open AccessLeft Supraclavicular (Virchow’s) Node Metastasis Detected Before Diagnosis of the Primary Infradiaphragmatic Tumor
Background and Purpose: Malignant infradiaphragmatic tumors that metastasize to the left supraclavicular (Virchow’s) node are relatively rare. Since Virchow's time, the survival rates of cancer patients have improved because of dramatic research advances in the epidemiology of cancer and the development of screening technologies and treatment methods. However, when metastasis is detected in the left supraclavicular node in patients with head and neck carcinoma, locating the primary cancer remains a difficult and time-consuming challenge. We report three cases of malignant infradiaphragmatic tumors diagnosed following the initial finding of left supraclavicular node (LSN) metastasis after surgery for tongue squamous cell carcinoma (follow-up period, range 18–62 months).Methods: In these cases, adenocarcinoma was diagnosed based on LSN biopsies, and a second primary tumor was found, including cholangiocarcinoma, bladder carcinoma, and prostate carcinoma.Results: CA19-9 and alpha-fetoprotein levels helped to diagnose cholangiocarcinoma. In the bladder carcinoma case, immunopathological examination of the metastatic LSN and bladder lesion showed GATA 3(+), and the tongue squamous cell carcinoma showed GATA 3(-). GATA 3 staining aided in the diagnosis of urothelial bladder cancer with LSN metastasis. In the prostate carcinoma case, PSA levels and weak FDG-PET/CT uptake aided the diagnosis process. This patient underwent bilateral orchiectomy and adjuvant hormonal therapy and survived for 47 months after the diagnosis of LSN metastasis. The other patients died within 1 year.Discussion and Conclusions: These cases suggest that the prognosis of malignant infradiaphragmatic tumors after LSN metastasis depends on the tumor characteristics and that rapid diagnosis is important for providing appropriate treatment.
- 23 May 2019
- Published by Elsevier in Current Problems in Cancer
- Vol. 43 (6) , 100481
Metastatic gastric adenocarcinoma of the tongue with initial symptoms of glossodynia
- 23 May 2019
- Published by Elsevier in Current Problems in Cancer
- Vol. 43 (6) , 100481
Metastatic gastric adenocarcinoma of the tongue with initial symptoms of glossodynia
- Open Access
- 19 October 2018
- Published by Springer Nature in BMC Oral Health
- Vol. 18 (1) , 166
Oral and maxillofacial surgery in patients undergoing dialysis for advanced renal disease: report of five cases
Perioperativemanagement of hemodialysis patients involves many difficulties. High mortality rate and circulatory or respiratory complications in these patients were reported. However, in such reports, there is no concrete information of perioperative management in hemodialysis patients to prevent surgical complications and successful outcomes. We retrospectively reviewed the cases of 5 hemodialysis patients who underwent oral surgery under general anesthesia between January 2005 and December 2017. Primary disease was oral squamous cell carcinoma (SCC) in 4 patients and mandibular ameloblastoma in 1 patient. Partial resection was performed in 2 cases, neck dissection in 1 case. Two cases underwent surgery including vascularized reconstruction. The patients were dialyzed the day before and after surgery for the control of fluid and electrolyte status. Patients received intraoperative and postoperative intravenous infusion of potassium-free solution at 20–40 mL/h. Erythropoiesis-stimulating agents (ESAs) were used on the day of hemodialysis during hospitalization. Nafamostat mesilate as an anticoagulant during hemodialysis were used from postoperative day (POD)1 to 7. From POD 1 to 10, cephalosporin as prophylactic antibiotics is adjusted to quarter from half the initial dose. The resuming time of oral intake was similar to that of other oral surgery patients without kidney disease. The daily intake limits of protein, salt and liquid were managed during hospitalization and no cases suffered from malnutrition. No cardiorespiratory complications occurred during the perioperative period. In a case of vascularized osteocutaneous scapular flap reconstruction, grafted scapular bone survived and scapular cutaneous flap necrotized. Necrotic tissue was debrided and split thickness skin was successfully used to cover the grafted scapular bone. Postoperative better result could be achieved if adequate perioperative management specific to hemodialysis patients is carried out. Vascularized flap reconstruction at oral and maxillofacial region in hemodialysis patients is beneficial treatment. Even if the first flap has wound complication secondary flap reconstruction is success and aesthetically better results could be achieved by the strict wound management and debridement.
- 19 October 2018
- Published by Springer Nature in BMC Oral Health
- Vol. 18 (1) , 166
Open AccessOral and maxillofacial surgery in patients undergoing dialysis for advanced renal disease: report of five cases
Perioperativemanagement of hemodialysis patients involves many difficulties. High mortality rate and circulatory or respiratory complications in these patients were reported. However, in such reports, there is no concrete information of perioperative management in hemodialysis patients to prevent surgical complications and successful outcomes. We retrospectively reviewed the cases of 5 hemodialysis patients who underwent oral surgery under general anesthesia between January 2005 and December 2017. Primary disease was oral squamous cell carcinoma (SCC) in 4 patients and mandibular ameloblastoma in 1 patient. Partial resection was performed in 2 cases, neck dissection in 1 case. Two cases underwent surgery including vascularized reconstruction. The patients were dialyzed the day before and after surgery for the control of fluid and electrolyte status. Patients received intraoperative and postoperative intravenous infusion of potassium-free solution at 20–40 mL/h. Erythropoiesis-stimulating agents (ESAs) were used on the day of hemodialysis during hospitalization. Nafamostat mesilate as an anticoagulant during hemodialysis were used from postoperative day (POD)1 to 7. From POD 1 to 10, cephalosporin as prophylactic antibiotics is adjusted to quarter from half the initial dose. The resuming time of oral intake was similar to that of other oral surgery patients without kidney disease. The daily intake limits of protein, salt and liquid were managed during hospitalization and no cases suffered from malnutrition. No cardiorespiratory complications occurred during the perioperative period. In a case of vascularized osteocutaneous scapular flap reconstruction, grafted scapular bone survived and scapular cutaneous flap necrotized. Necrotic tissue was debrided and split thickness skin was successfully used to cover the grafted scapular bone. Postoperative better result could be achieved if adequate perioperative management specific to hemodialysis patients is carried out. Vascularized flap reconstruction at oral and maxillofacial region in hemodialysis patients is beneficial treatment. Even if the first flap has wound complication secondary flap reconstruction is success and aesthetically better results could be achieved by the strict wound management and debridement.
- 1 October 2014
- Published by Japan Prosthodontic Society in Journal of Prosthodontic Research
- Vol. 58 (4) , 259-266
Functional outcomes with dental prosthesis following simultaneous mandibulectomy and mandibular bone reconstruction
This study sought to ascertain masticatory outcomes in patients who underwent mandibulectomy or hemimandibulectomy together with mandibular bone reconstruction to allow for placement of a removable dental prosthesis. Perioperative changes in masticatory performance, masticatory ability for solids, and patients' subjective satisfaction were evaluated for 101 patients who had mandibulectomy immediately followed by bone reconstruction. Differences in masticatory performance and masticatory ability for solids after surgery were determined according to occlusal support after surgery and whether the patient was wearing a removable dental prosthesis or not. Occlusal support areas were classified according to Eichner's classification. Preoperative Eichner's class A patients had no experience of wearing a dental prosthesis before surgery and after surgery did not want one. Their masticatory performance was better than that of patients who wanted a dental prosthesis after surgery. Retrospective analysis of postoperative Class B and C patients revealed that masticatory performance was lower in those who wanted a dental prosthesis than in those who did not want one. When patients wore a dental prosthesis after surgery, masticatory performance was markedly improved over not wearing it. All patients' subjective satisfaction was significantly improved after surgery. Increasing the number of occlusal support areas by wearing a removable dental prosthesis after simultaneous mandibulectomy or hemimandibulectomy and mandibular bone reconstruction may improve masticatory functions. Those professional involved in the rehabilitation for the mandibular defect should be mindful that masticatory functions after such surgeries were affected by the masticatory functions before surgery and the number of occlusal support areas after surgery.
- 1 October 2014
- Published by Japan Prosthodontic Society in Journal of Prosthodontic Research
- Vol. 58 (4) , 259-266
Functional outcomes with dental prosthesis following simultaneous mandibulectomy and mandibular bone reconstruction
This study sought to ascertain masticatory outcomes in patients who underwent mandibulectomy or hemimandibulectomy together with mandibular bone reconstruction to allow for placement of a removable dental prosthesis. Perioperative changes in masticatory performance, masticatory ability for solids, and patients' subjective satisfaction were evaluated for 101 patients who had mandibulectomy immediately followed by bone reconstruction. Differences in masticatory performance and masticatory ability for solids after surgery were determined according to occlusal support after surgery and whether the patient was wearing a removable dental prosthesis or not. Occlusal support areas were classified according to Eichner's classification. Preoperative Eichner's class A patients had no experience of wearing a dental prosthesis before surgery and after surgery did not want one. Their masticatory performance was better than that of patients who wanted a dental prosthesis after surgery. Retrospective analysis of postoperative Class B and C patients revealed that masticatory performance was lower in those who wanted a dental prosthesis than in those who did not want one. When patients wore a dental prosthesis after surgery, masticatory performance was markedly improved over not wearing it. All patients' subjective satisfaction was significantly improved after surgery. Increasing the number of occlusal support areas by wearing a removable dental prosthesis after simultaneous mandibulectomy or hemimandibulectomy and mandibular bone reconstruction may improve masticatory functions. Those professional involved in the rehabilitation for the mandibular defect should be mindful that masticatory functions after such surgeries were affected by the masticatory functions before surgery and the number of occlusal support areas after surgery.
- 1 May 2013
- Published by Elsevier in Oral Oncology
- Vol. 49, S55
OP131